Health Care Business Group

Similar documents
Inge Thulin. Chairman of the Board, President & Chief Executive Officer. December 16, M. All Rights Reserved.

Mike Roman. Chief Operating Officer & Executive Vice President. Bank of America Merrill Lynch Global Industrials Conference.

Safety of the Food Supply - a Worldwide Problem

Inge Thulin. Chairman of the Board, President and CEO. Bernstein Strategic Decisions Conference. June 1, 2017

BD Strategy Overview. Advancing the world of health. Vincent A. Forlenza Chairman, Chief Executive Officer and President

New Cardinal Health (Post-Spin)

North America Surgical Sutures Market Outlook to 2020

Japan Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020

SAMPLE. North America Trauma Fixation Procedures Outlook to 2020

France Spinal Surgery Procedures Outlook to 2020

Brazil Gastric Balloon Procedures Outlook to 2020

34 th Annual J.P. Morgan Healthcare Conference

SAMPLE. Mexico Orthopedic Prosthetics Market Outlook to Reference Code: GDMECC0156DB. Publication Date: February 2014

BRIC Surgical Sutures Market Outlook to 2020

United Kingdom Tissue Engineered - Skin Substitutes Market Outlook to 2020

Cardinal Health overview and strategic priorities

Spain Knee Replacement Procedures Outlook to 2020

Germany Tissue Engineered - Skin Substitutes Market Outlook to 2020

J.P. Morgan Healthcare Conference January 10, 2018

France Pressure Relief Devices Market Outlook to 2020

Consumer Business Group

H.C. Shin. March 17, Executive Vice President, International Operations M. All Rights Reserved.

Brazil Capsule Endoscopy Procedures Outlook to 2020

SAMPLE. South Korea MRI Systems Market Outlook to Reference Code: GDMECC0287DB. Publication Date: March 2014

China Biopsy Devices Market Outlook to 2020

United States Orthopedic Bone Cement and Casting Materials Market. Outlook to 2020

South Korea Ultrasound Systems Market Outlook to 2020

Jefferies 2014 Global Healthcare Conference June 3, 2014 NYSE: Q

Jefferies Healthcare Conference

itero - Scan Every Patient at Every Visit

Anika Therapeutics, Inc.

UPS Healthcare Supply Chain Vital Signs

Innovation in medical devices as response to Europe's healthcare challenges. Industry's viewpoint

Philips: a focused leader in HealthTech

Global In-Vitro Diagnostic Market Report

Santen Acquisition of InnFocus, Developer of MicroShunt Glaucoma Implant Device

Improve your probability. of success

Capturing the HealthTech opportunity

2009 INVESTOR DAY. Medical. Allan Ross President Medical December 17, 2009

Managing Across the Care Continuum: Distribution to Alternate Sites

Global Low Temperature Sterilization Market: Industry Analysis & Outlook

TRUSTED GLOBAL LEADER

Global Pre-filled Syringes Market-Data, Analysis and Forecast to 2024

Global IVD Market

Anika Therapeutics, Inc.

Tecan Group 34 th Annual J.P. Morgan Healthcare Conference DR. DAVID MARTYR, CEO JANUARY 14, 2016 SAN FRANCISCO, USA

2009 INVESTOR DAY. BioPharmaceuticals. Ken Frank President BioPharmaceuticals December 17, Sustainable, Profitable Growth

Driving global scale and category leadership in Male Grooming. Caroline Clarke, CEO Personal Care

Building growth momentum through personal health solutions. Roy Jakobs Chief Business Leader Personal Health

Cautions Concerning Forward-looking Statements

Country Coverage. Regional Coverage. Global Coverage. Company Coverage

QIAGEN Sample & Assay Technologies From Discovery to Patient

Progress Report. Jouko Karvinen CEO of Medical Systems

SAMPLE. Bracco Imaging S.p.A.Market Share Analysis. Bracco Imaging S.p.A. Market Share Analysis GDME0639CDB / Published January 2013

To Our. written over 70 years ago, unites & inspires the employees of Johnson & Johnson.

Investor Overview Presentation ADVANCING LIFE SCIENCE TOGETHER

Enabling Growth. H.C. Shin Vice Chair and Executive Vice President. December 12, 2017

R1 to Acquire Intermedix and Selected as RCM Services Provider for Ascension Physician Business

Ascom Investor Presentation. May 2018

AVITA Medical RECELL System Health Economic Data Projects USD $28 Million in Annual Savings at a Single Major Burn Center Versus Standard of Care

2015 Investor Meeting

NuVasive, Inc. Acquisition of Ellipse Technologies, Inc. January 5, 2016

CEO s Round Table June

Safety & Graphics Business Group

Capital Market Day June 12, 2012

UBS 2007 Global Life Sciences Conference. September 24, 2007

PerkinElmer, Inc. JP Morgan Global Healthcare Conference. Robert Friel, Chairman and CEO January 14, 2015 HUMAN HEALTH ENVIRONMENTAL HEALTH

2018 Investor Day Consumer Business Group

Investor Presentation May 2018

Jefferies 2017 Global Healthcare Conference. June 7, 2017

DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE

Jefferies 2018 Global Healthcare Conference. June 7, 2018

Teva Pharmaceutical Industries Ltd. J.P. Morgan Healthcare Conference. Kåre Schultz President and CEO January 7, 2019

MEDICATION DELIVERY. David Ferguson GM, Medication Delivery. May 21, 2018

GE Growth Strategy. Business Development & Organic Growth. Hwang Soo President of GE Korea Feb. 12, 2008

STRYKER ANALYST MEETING. September 2014

Globaldata. Publisher Sample

Universal Biosensors, Inc.

Alliqua BioMedical Investor Presentation August 2017 NASDAQ: ALQA

A Leading Global Health Care Group

Pfizer To Acquire Hospira

Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Emerging Pharmaceutical Market - Indonesia and the Philippines -Introduction 3 Emerging

Plumbing Products. Richard O Reagan / Group President, Global Plumbing

Investor Presentation RBC Capital Markets Global Healthcare Conference February 22, 2017

GSK Consumer Health Supplier Relationship Team (SRT) Concept. Yassine Laqbayli Supplier Interface Manager GSK AGENDA TOPICS

Stephens Fall Investment Conference

MORGAN STANLEY LAGUNA CONFERENCE Dan Comas September 15, 2016

Portada Victoria CAPITAL MARKETS DAY 25 JANUARY 2018

ICON plc. 10th Jan Ciaran Murray CEO Steve Cutler CEO Designate. JP Morgan 35TH Annual Healthcare

Corporate Philosophy and Vision, Brand Mark, Business Management Goals and Other Policies of Mitsubishi Tanabe Pharma Corporation

National Foundation for Women Legislators Annual Meeting September 12, 2015 Tara Ryan Vice President, State Government Advocacy

FOR ANIMALS FOR HEALTH FOR YOU

Genomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research

Edwards Lifesciences

From discussion to implementation: How to negotiate and implement a risk-sharing agreement

AMBITION TO LEAD THE ZERO CARBON TRANSITION

Health Care Worldwide. Crédit Suisse Global Credit Products Conference October 1, Barcelona

Implementation of Portfolio Strategy in Today s Global Economy

JEFFERIES 2015 GLOBAL HEALTHCARE CONFERENCE JUNE 3, 2015 NACHUM HOMI SHAMIR PRESIDENT AND CHIEF EXECUTIVE OFFICER

Transcription:

Health Care Business Group Joaquin Delgado, Executive Vice President December 17, 2013 2013 3M. All Rights Reserved.

2 3M CONFIDENTIAL 2013 3M. All Rights Reserved.

Saving and improving lives around the world Number of deaths per year in U.S. from preventable hospital infections 87,000 People who suffer from asthma, and many breathe easier with 3M inhalers 150 million 3 million 300+ million Healthy and beautiful smiles, thanks to 3M dental restoratives & orthodontic solutions 100+ million 3M technologybased solutions improve health outcomes and reduce costs People die each year from food poisoning People who suffer from diabetes and other chronic illnesses; many helped by our solutions that help protect & restore skin integrity 3 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

Agenda Business Overview and Market Landscape Strategic Playbook Developed and Developing Markets Opportunities Our Technologies & Portfolio 4 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

3M Health Care Businesses Preventing Healthcare Associated Infections Innovating for Wound and Skin Care and Vascular Access Securement Improving Healthcare Efficiency, Quality and Reimbursement Making Smiles Healthy and Beautiful Customizing Pharmaceutical Drug Delivery Solutions Monitoring Food Safety Infection Prevention Critical & Chronic Care Health Information Systems Oral Care Drug Delivery Systems Food Safety A synergistic portfolio with breadth and depth across the healthcare industry 5 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

The Health Care Business generates solid and consistent profitable growth $6.0 $4.0 $2.0 Sales CAGR of 5% $B $5.0 $5.1 $5.4 $4.3 $4.3 $4.5 Drug Delivery 9% Health Info Sys 11% Sales by Business 2013e Food Safety 5% Infection Prevention 29% $0.0 2008 2009 2010 2011 2012 2013e Critical & Chronic Care 21% Oral Care 25% $2.0 $B Operating Income CAGR of 7% Sales by Geography 2013e LAC 11% $1.0 $1.2 $1.3 $1.4 $1.5 $1.6 $1.7 APAC 16% U.S. 43% $0.0 2008 2009 2010 2011 2012 2013e Europe 30% 78% Developed Economies; 22% Developing 6 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

3M Health Care Business Group portfolio strengths and synergies Technology Platforms Business Group Divisions Brand Food Safety Health Information Systems Medical Oral Care Supply Chain Drug Delivery Systems Global Presence Leveraging 3M s core strengths to provide total solutions for the healthcare industry 7 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

Healthcare is a large, global growth opportunity Large, Growing Global Healthcare Market Global Market Penetration Opportunity $383B $92B $5B $7T Developed Countries Developing Countries 3M Sales Healthcare Addressable Market *Source: Medical etrack and Espicom 2012 $USD 2013-2017 Growth WW Expenditures $7.0T 4.6% Developed Countries Expenditures Developing Countries Expenditures $5.4T 2.9% $1.6T 9.8% and we are uniquely positioned to gain market share in both Developed and Developing countries 8 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

The Healthcare landscape Key Mega Trends Increased demand for access to Healthcare around the world People living longer Increased incidence of chronic diseases Use of comprehensive health data becoming more ubiquitous Advances in biologics and regenerative medicine Global Forces Shaping the Market More Access Improved Quality & Better Clinical Outcomes Healthcare Delivery at Lower Cost Solutions-based Technology Development Industry Success Enablers Prevention Digitization Shift to Lower Cost Delivery Sites Evidence-Based Solutions 9 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

Business Overview and Market Landscape Strategic Playbook Developed and Developing Markets Opportunities Our Technologies & Portfolio 10 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

3M Health Care Business Group strategic playbook 3M Strategies Playbook Expand Relevance to our Customers and our Presence in the Marketplace Gain Profitable Market Share and Accelerate Market Penetration Everywhere Accelerate growth in developing countries Gain profitable market share in developed countries Growth Invest in Innovation: Invigorate Existing Market Opportunities and Focus on Emerging Megatrends People & Capabilities R&D Invest in Innovation, Market Coverage and Localization Build High Performing and Diverse Global Talent Portfolio Prioritize Platforms and Geographies Intensify Capabilities to Achieve Regional Self-Sufficiency Drive Consistent Superior Levels of Operational Excellence Operational Excellence Liberate Funds for Investment 11 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

Business Overview and Market Landscape Strategic Playbook Developed and Developing Markets Opportunities Our Technologies & Portfolio 12 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

Gaining profitable market share in developed countries Priorities Key Platforms to Maximize Customer Relevancy Medical Health Info. Systems Oral Care Drug Delivery Food Safety Expand Coverage Across the Continuum of Care Align Portfolio to Targeted Care Delivery Points Vascular Access Skin Integrity Advanced Wound Care 360 Encompass TM Procedure-Based Solutions Digital Materials Prevention Inhalation Drug Delivery Molecular Detection Systems Increase Number of New-to-the-World Products Securement Patient Warming Healthcare Analytics Digital Ortho Clarity TM Ceramics Transdermal Drug Delivery Hygiene Monitoring Sterilization Incognito TM 13 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

Expanding coverage across the continuum of care (USA) Hospital Surgery Center Wound Clinic Long-term Acute Care Physician Office Extended Care Home Health Oral Care 100% 3M USA Penetration Rates 80% 60% 40% 20% 0% 3M Penetration Rate Addressable Market Opportunity Upside in the USA and significant opportunity to expand into other developed markets 14 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

Building growth faster and more productively in developing countries Expand Coverage Advance Standards of Care Tailor Portfolio Invest in Commercialization Competencies Targeted expansion to increase sales coverage Active participation in advancing healthcare standards Expand local laboratory and manufacturing capabilities Enhance competence in sales, marketing, clinical and regulatory areas Continue to strengthen our commercialization and market development capabilities 15 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

Developing markets strategy produces results China 15% growth Local Lab Increasing R&D and technical service competencies Developing localized and new-to-theworld products Localizing clinical research Local Manufacturing Medical products plant Orthodontic products plant Brazil 21% growth Increasing R&D and technical service competencies Expanding R&D capabilities to enhance localized product pipeline Localizing clinical research Oral Care products plant Medical products plant Growth rates are Sept YTD Organic Local Currency 16 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

Business Overview and Market Landscape Strategic Playbook Developed and Developing Markets Opportunities Our Technologies & Portfolio 17 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

Tailoring our new product development strategy Developed Countries: Innovation Developing Countries: Penetration 2013 2017 2013 2017 Shift innovation pipeline towards Adjacent and Transformational Products Localize core portfolio and advance new-to-the market local product development Transformational Products Replacement New Products New-to-Market Products Product Localization 18 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

Healthcare Megatrends 3M Technologies Healthcare megatrends and 3M technologies drive innovation Increased demand for access to Healthcare around the world Earlier detection of pathogens in Healthcare facilities and food streams People living longer Increased incidence of chronic diseases Preventing harmful and costly Healthcare associated infections Use of comprehensive health data becoming more ubiquitous Advances in biologics and regenerative medicine Providing cost-effective therapeutic solutions in critical and chronic care Digitization of information to improve accuracy and compliance, and make better decisions 19 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

High impact R&D programs: creating the future Detection Prevention Intervention Digitization Novel Food Safety Detection Technologies In-Office Preventive Dental Care Biologic Wound Care Integrated Oral Digital Technologies Toxins, Allergens, and Residues Market opportunity >$700M New materials and devices to identify and prevent oral conditions Market opportunity >$150M Bio-active wound closure, accelerated healing Market opportunity $650M Transform analogue procedures to digital Market opportunity $750M Enabling Novel Surgical Solutions Healthcare Data Analytics Assisting surgeons in open and minimally invasive procedures Market opportunity $500M Improve quality and mitigate risk in care delivery Market opportunity $3.7B 20 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

Acquisitions have been important to Healthcare s success Code 3 Corporation (Health Information) (Dental products) (Orthodontic products for developing markets) (Computer-assisted coding) 1987 2000 2006 2007 2010 2012 (Orthodontic products) (Microbiological food safety testing) (Patient warming) Combining acquisitions with organic innovation to expand the breadth and depth our portfolio 21 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

We acquired Arizant Healthcare in 2010 Acquisition combined with 3M capabilities drives profitable, global growth Forced Air Patient Warming Gown Forced Air Warming Blankets Fluid Warming Multiple new products launches since acquisition and strong future pipeline Expanding solutions beyond traditional operating room setting Expanding the business across 3M s footprint; products now sold in 70+ countries versus 36 countries when acquired Core Temperature Monitoring New product launch since acquisition 2013e Local Currency Growth % Developed Countries Developing Countries 6% 15% Exceeding original growth forecast Delivering savings Revenue synergies taking hold 22 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

3M is well positioned to thrive in a dynamic healthcare market Attractive portfolio Global footprint Arsenal of leading technologies Growth funded by operational excellence An inspired, dedicated team Improving Every Life each and every day 23 Investor 2014 3M Meeting Outlook Meeting, December December 17, 201317, 2013

2013 3M. All Rights Reserved.